Drug Shortage Report for MYLAN-OLANZAPINE ODT

Last updated on 2017-07-17 History
Report ID 9162
Drug Identification Number 02382733
Brand name MYLAN-OLANZAPINE ODT
Common or Proper name OLANZAPINE ODT
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) OLANZAPINE
Strength(s) 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30BL
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-01
Estimated end date Unknown
Actual end date 2017-07-12
Shortage status Resolved
Updated date 2017-07-17
Company comments This product is discontinued and reported under discontinuation ID 16018.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-07-17 French Compare
v3 2017-07-17 English Compare
v2 2017-05-05 French Compare
v1 2017-05-05 English Compare

Showing 1 to 4 of 4